Pinto, Ana Catarina <br/><br/>
Liposomal imatinib-mitoxantrone combination: formulation development and therapeutic evaluation in an animal model of prostate cancer.  [electronic resource] 

 -  The Prostate  Jan 2011 
 - 81-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0045 
<br/><br/><label>Standard No.: </label>10.1002/pros.21224  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Benzamides<br/>Cell Line, Tumor<br/>Disease Models, Animal<br/>Humans<br/>Imatinib Mesylate<br/>Liposomes<br/>Male<br/>Mice<br/>Mice, Nude<br/>Mitoxantrone--administration & dosage<br/>Piperazines--administration & dosage<br/>Prostatic Neoplasms--drug therapy<br/>Pyrimidines--administration & dosage<br/>Xenograft Model Antitumor Assays